Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort

The eye care company Alcon, leading worldwide, has made its PRECISION1 daily disposable contact lenses available in India. Lenses featuring SMARTSURFACE technology are now available, created for up to 16 hours of wearing comfort to satisfy the increa

Roche's IMforte Trial Shows Survival Gains in ES-SCLC Therapy

Roche has reported favorable outcomes from the Phase III IMforte trial involving Tecentriq (atezolizumab) in conjunction with lurbinectedin (Zepzelca®) as a first-line maintenance therapy

India Gets Its First Bluetooth CGM as Tracky Redefines Diabetes Monitoring

Tracky, a brand of DrStore Healthcare Services and a health tech startup, launched India's first Bluetooth Continuous Glucose Monitor

Dr Reddy's Partners with Alvotech to Expand in Oncology Biosimilars

Dr Reddy's Laboratories has made a strategic partnership with global biotechnology company Alvotech for the co-development and commercialization of a biosimilar of Keytruda

CDSCO Clears Phase III Trial of Tetanus Vaccine in Pregnant Women

The major boost for maternal immunization in New Delhi, the Subject Expert Committee (SEC) on Vaccines of the Central Drugs Standard Control Organisation

Allarity Begins Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer

Allarity Therapeutics, a Phase 2-stage biopharmaceutical with activities in Copenhagen and Boston, has formally enrolled its first patient in its newly launched Phase 2 trial

Zydus to acquire US biotech firm Agenus in Emeryville and Berkeley

Zydus Lifesciences is entering the global biologics contract development and manufacturing (CDMO) arena with its acquisition of two biologics facilities from Agenus at Emeryville and Berkeley in California...

TDB Drives Local Innovation in Complex Pharma Excipients

Indian Technology Development Board (TDB), which operates under Department of Science and Technology (DST), has provided finance support to excipient producer of pharmaceuticals

Glenmark Announced Promising Results For Blood Cancer Drug

Ichnos Glenmark Innovation (IGI), a clinical-stage biotech collaboration between New York-based Ichnos Sciences and India’s Glenmark Pharmaceuticals, has presented encouraging Phase 1 data for its...

AyushSuraksha Portal launched address misleading advertisements and ADR

Following direction from the Supreme Court of India in July 2024, the Ministry of Ayush has introduced AyushSuraksha Portal to handle fake advertisements and report adverse drug reactions (ADRs)...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.